more_reports

The Latest Life Sciences Tools & Diagnostics Articles from Streetwise Reports

AI Collaboration Expands to Accelerate Cancer Drug Discovery

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) has broadened its partnership with Variational AI to refine next-generation ATR inhibitors using generative AI. The agreement aims to streamline lead optimization for the company's kt-5000 series of small-molecule cancer drug candidates.
Tags: Life Sciences Tools & DiagnosticsBiotechnology / Pharmaceuticals

Expanded AI Collaboration Advances Optimization of Cancer Drug Candidates

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) has expanded its partnership with Variational AI to advance optimization of its kt-5000 ATR inhibitor series. Learn how the agreement deepens the company's use of generative AI to refine small-molecule drug candidates and accelerate preclinical selection.
Tags: Biotechnology / PharmaceuticalsLife Sciences Tools & Diagnostics

Strategic Inflection: Scaling Multi-Condition Platform in Financial Transition

  ()
Current valuation disproportionately penalizes DarioHealth for balance sheet constraints while assigning negligible value to its contracted growth and superior margin profile. As the revenue from the 2025 bookings cohort begins to layer in during the first half of 2026, we anticipate a re-rating of the equity toward multiples consistent with its high-growth digital health peers.
Tags: Healthcare ServicesLife Sciences Tools & Diagnostics

AI-Powered Healthcare Co. Gains Traction as US Expansion Accelerates

  ()
John Newell of John Newell & Associates shares why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.
Tags: Life Sciences Tools & Diagnostics

Clean Tech Co.'s 'Forever Chemicals' Solution Featured in Industry Magazine

  ()
BioLargo Inc. (BLGO:OTCQX) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) is prominently featured in Chemical Engineering magazine for its advancements in electrostatic PFAS treatment technology. Find out why one expert likes this stock long-term.
Tags: Life Sciences Tools & DiagnosticsTechnologySpecial Situations

Water Treatment Firm Finds High-Performance Solution for $2.99B PFAS Market

  ()
Chemical Engineering magazine features BioLargo Inc. (OTCQX:BLGO) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) for its advancements in electrostatic PFAS treatment technology. Read why one expert likes this stock long-term.
Tags: Special SituationsTechnologyLife Sciences Tools & Diagnostics

Cleantech Co. Advances Antimicrobial Wound Care Breakthrough

  ()
Cleantech innovation company BioLargo Inc. (BLGO:OTCQX) announced that subsidiary Clyra Medical Technologies is making significant strides. Read why one analyst says the technology is on "the cusp of commercialization."
Tags: Medical DevicesLife Sciences Tools & Diagnostics

Biotech Battles FDA, Target Price Shows Potential 90% Gains

Research Report
  ()
Capricor Therapeutics Inc. (CAPR:NASDAQ) has recently been involved in a "tug-of-war with the FDA." Read on to see why one Roth analyst still rates this stock as a Buy.
Tags: Life Sciences Tools & Diagnostics

AI Healthcare Stock Showing Signs of a Base Breakout

Contributed Opinion
  ()
John Newell of John Newell & Associates explains why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.
Tags: Life Sciences Tools & Diagnostics

Co.'s Graphene Used in New Screening Test for Lung Cancer

  ()
HydroGraph Clean Power Inc.'s (HG:CSE; HGRAF:OTCQB; M98:FSE) patented, high-purity material has applications in healthcare, as in this case, but also in numerous other industries. Read on to learn why some experts say this company could be a future 100-bagger.
Tags: Life Sciences Tools & DiagnosticsBattery Metals

Showing Results: 1 to 10 of 10